ORGO Organogenesis Holdings Inc.

1d ago, source: Seeking Alpha

Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the ...

Organogenesis Holdings Inc. (NASDAQ:ORGO) Q4 2023 Earnings Call Transcript

1mon ago, source: InvestingChannel on MSN

Organogenesis Holdings Inc. isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter (see ...

Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance

1mon ago, source: WDAF-TV

Gillheeney, Sr., President and Chief Executive Officer of Organogenesis. "Despite the expected operating environment challenges, we delivered revenues within the lower end of our guidance.

Organogenesis Holdings Inc Class A

16d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case

17d ago, source: Business Insider

CANTON, Mass., April 03, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (NASDAQ: ORGO) a leading regenerative medicine company focused on the development, manufacture, and commercialization ...

Buy Rating Affirmed for Organogenesis Holdings Amid Stable Product Pricing and Positive Market Dynamics

1mon ago, source: Business Insider

Organogenesis Holdings (ORGO) Company Description: Organogenesis Holdings, Inc. is a regenerative medical company. It focuses on the development, manufacture and commercialization of product ...

Organogenesis Holdings Inc. (ORGO)

4d ago, source: Yahoo Finance

*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...

Organogenesis Holdings Inc - Ordinary Shares - Class A

15d ago, source: U.S. News & World Report

Organogenesis Holdings, Inc. is a regenerative medical company, which engages in the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and ...

Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance

1mon ago, source: Stockhouse

Gillheeney, Sr., President and Chief Executive Officer of Organogenesis. "Despite the expected operating environment challenges, we delivered revenues within the lower end of our guidance. Looking ...

Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance

1mon ago, source: ADVFN

Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care ...